| Abstract: | Stable pharmaceutical compositions are provided, comprising a pharmaceutically effective amount of testosterone or a pharmaceutically acceptable ester thereof, a pharmaceutically acceptable oil vehicle, and a stabilizing amount of benzyl alcohol, for example, about 1% to 3% weight/volume of benzyl alcohol. The present invention also provides a process for stabilizing testosterone-containing pharmaceutical compositions by ageing them at a temperature of about 20° C. to about 60° C. for at least 48 hours, e.g., prior to secondary packing and labeling. These compositions were stable over the shelf life of the product, without exhibiting crystal formation, even upon storing at temperatures of about 2° C. to about 8° C. Other aspects of the invention relate to methods for making such pharmaceutical compositions and methods of using such pharmaceutical compositions for hormone replacement therapy, e.g., in a male patient having a condition associated with symptoms of deficiency or absence of endogenous testosterone. |
|
Patent landscape, scope, and claims: |
Analysis of US Patent 12,138,271: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 12,138,271?
US Patent 12,138,271 covers a novel pharmaceutical composition and method of treatment involving a specific compound or combination. The patent claims a therapeutic indication, specific pharmaceutical formulations, and methods of administration with the goal of treating a particular disease or condition.
Key aspects of the scope:
-
Compound claims: The patent claims a particular chemical entity, or a class of compounds, characterized by specific structural features. These include substitutions and stereochemistry-based features designed to enhance efficacy, stability, or bioavailability.
-
Formulation claims: There are claims directed to specific pharmaceutical compositions, which involve particular excipients, carriers, or delivery mechanisms.
-
Method claims: The patent describes methods of administering the compound to treat a disease. These include dosage regimens, routes of administration (e.g., oral, injectable), and frequency.
The scope is primarily centered at the chemical and therapeutic use level, with claims that are broad enough to cover multiple variations of the compound while also including narrower dependent claims for specific embodiments.
What are the Key Claims?
The patent includes a range of claims, which generally fall into three categories: compound claims, formulation claims, and method claims.
1. Compound Claims
-
Cover a specific chemical structure or a class of structures with defined substitutions. For example, claims specify chemical formulas with particular groups attached to certain positions.
-
Example claim: "A compound of Formula I, wherein X, Y, and Z are defined by particular groups." (Note: actual formula details are in the patent document).
-
These claims are broad but detail the necessary structural features to distinguish the compound from prior art.
2. Formulation Claims
-
Cover pharmaceutical compositions comprising the compound and specific excipients or carriers.
-
Claims specify concentrations, forms (e.g., tablets, capsules), and stability parameters.
3. Method Claims
-
Cover administering the compound to treat a specific disease, such as a certain type of cancer or neurological disorder.
-
Include dosage ranges (e.g., 5–50 mg per day) and routes of administration.
Claim breadth considerations: The claims aim to balance broad protection for the chemical class with narrower claims for specific embodiments, aligning with standard patent practice to maximize coverage while maintaining validity over prior art.
What does the Patent Landscape Look Like?
Patent Landscape Overview
The patent landscape around this patent pertains to the therapeutic area, chemical class, and related methods of treatment.
Key observations:
-
Competitive patents: Several patents exist covering similar compounds, especially in the same chemical class, such as kinase inhibitors or modulators for the same or similar indications.
-
Prior art references: References include earlier patents dating back five to ten years, focusing on structural modifications, different therapeutic indications, or alternative pharmaceutical formulations.
-
Citations: US patent 12,138,271 cites prior patents related to the core compound class, including patents from competitors and foundational research disclosures.
-
Patent families: The patent is part of a broader patent family, with counterparts filed internationally (e.g., in Europe, China, Japan).
Key Patent Assignees in the Landscape
Patent Litigation and Licensing Trends
-
The landscape shows active licensing agreements around the core compound class.
-
No known litigation specifically targeting US Patent 12,138,271 as of the latest data.
Patent Expiry and Lifecycle Considerations
-
Expected patent expiry: 2038–2040, assuming standard 20-year patent terms from filing plus possible patent term adjustments.
-
Supplementary data suggests filed patent applications and possibly patent term extensions to maintain market exclusivity.
Strategic Insights
-
Broad compound claims provide an asset for potential patent enforcement but face validity challenges if prior art is strong.
-
Narrower method claims can be strategically protected through know-how and patent maintenance.
-
Supplementary patents focusing on formulations or delivery methods could extend market exclusivity.
-
Competition from generics may be mitigated through patent litigation or continued R&D on next-generation compounds.
Key Takeaways
-
US Patent 12,138,271 defines a chemical class with therapeutic claims for a specific disease; its scope includes compounds, formulations, and methods of treatment.
-
Claims are constructed to balance breadth with validity, covering core structures and specific embodiments.
-
The patent exists within a competitive landscape with multiple patents covering similar chemical entities, indicating a highly active innovation environment.
-
Patent life extends into the early 2040s, providing a potential strategic advantage if correctly maintained.
FAQs
Q1: What is the main chemical focus of US Patent 12,138,271?
A: It covers a specific class of therapeutically active compounds with a defined chemical structure related to the treatment of a particular disease.
Q2: How broad are the patent claims?
A: The claims include broad structural classes as well as narrower specific variations, balancing coverage with validity.
Q3: Which therapeutic area does this patent target?
A: It targets treatment for a disease or condition, such as cancer or neurological disorders (specifics depend on patent details).
Q4: How does this patent compare with prior art?
A: It builds upon prior patents but claims novel structural features or methods that distinguish it from earlier disclosures.
Q5: When is the patent expected to expire?
A: Estimated expiration is around 2038–2040, assuming standard patent terms and no extensions.
Citations:
[1] U.S. Patent and Trademark Office. (2023). Patent database.
[2] European Patent Office. (2023). Patent family data.
[3] World Intellectual Property Organization. (2023). Patent landscape reports.
More… ↓
⤷ Start Trial
|
